Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016-Reference-Cited by-同舟云学术

Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016

Published:2020-08 Issue:4 Volume:20 Page:e410-e422
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Thomas Alexandra^ORCID,Rhoads Anthony^ORCID,Suhl Jonathan,Conway Kristin M.^ORCID,Hundley William G.,McNally Lacey R.,Oleson Jacob,Melin Susan A.,Lynch Charles F.,Romitti Paul A.

Funder

Centers for Disease Control and Prevention

National Cancer Institute

Nealie Belk Stevens Fund for Breast Cancer Research

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Subtype-dependent relationship between young age at diagnosis and breast cancer survival;Partridge;J Clin Oncol,2016

2. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling;Azim;Clin Cancer Res,2012

3. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression;Anders;J Clin Oncol,2008

4. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics;Sweeney;Cancer Epidemiol Biomarkers Prev,2014

5. Biology of breast cancer in young women;Azim;Breast Cancer Res,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes;Current Oncology;2024-01-24

2. Simultaneous Detection of Multiple Tumor-targeted Gold Nanoparticles in HER2-Positive Breast Tumors Using Optoacoustic Imaging;Radiology: Imaging Cancer;2023-05-01

3. Otuz yaş altı meme kanserli kadınların klinikopatolojik özellikleri ve sağkalım sonuçları;Akdeniz Medical Journal;2023-01-01

4. Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy;JNCI: Journal of the National Cancer Institute;2022-05-05

5. Breast cancer and pregnancy: Why special considerations prior to treatment are needed in multidisciplinary care;BioScience Trends;2021-10-31